RRBP1 overexpression is associated with progression and prognosis in endometrial endometrioid adenocarcinoma
Abstract Background Currently, ribosome-binding protein 1 (RRBP1) is considered to be a novel oncogene that is overexpressed in colorectal cancer, lung cancer, mammary cancer, esophageal cancer and other carcinomas. However, the relationship between RRBP1 and endometrioid-type endometrial carcinoma...
Main Authors: | Shuang Liu, Mu Lin, Hongying Ji, Jing Ding, Jiaqi Zhu, Rong Ma, Fanling Meng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-01-01
|
Series: | Diagnostic Pathology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13000-019-0784-6 |
Similar Items
-
Hypomethylated RRBP1 Potentiates Tumor Malignancy and Chemoresistance in Upper Tract Urothelial Carcinoma
by: Hao-Lun Luo, et al.
Published: (2021-08-01) -
RRBP1 depletion of bone metastatic cancer cells contributes to enhanced expression of the osteoblastic phenotype
by: Rui Chen, et al.
Published: (2022-12-01) -
Analysis of the association of ANO3/MUC15, COL4A4, RRBP1, and KLK1 polymorphisms with COPD susceptibility in the Kashi population
by: Lifeng Tang, et al.
Published: (2022-05-01) -
Gastric mucosa as a rare recurrence location of endometrial endometrioid adenocarcinoma
by: Kathleen Lundeberg, et al.
Published: (2024-06-01) -
CXCR3 predicts the prognosis of endometrial adenocarcinoma
by: He Dong, et al.
Published: (2023-02-01)